OrbiMed

Summary

In 1989 was created OrbiMed, which is appeared as VC. The venture was found in North America in United States. The leading representative office of defined VC is situated in the New York.

Besides them, we counted 15 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the OrbiMed, startups are often financed by New Enterprise Associates, Kearny Venture Partners, Sequoia Capital. The meaningful sponsors for the fund in investment in the same round are Deerfield, Alta Partners, Topspin Partners. In the next rounds fund is usually obtained by Versant Ventures, Venrock, OUP (Osage University Partners).

Among the most popular portfolio startups of the fund, we may highlight Loxo Oncology, Receptos, Avanir Pharmaceuticals. Among the most popular fund investment industries, there are Biotechnology, Clinical Trials. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.

Speaking about the real fund results, this VC is 22 percentage points more often commits exit comparing to other organizations. The important activity for fund was in 2017. Despite it in 2019 the fund had an activity. The common things for fund are deals in the range of 10 - 50 millions dollars. The typical startup value when the investment from OrbiMed is 100-500 millions dollars. Opposing the other organizations, this OrbiMed works on 6 percentage points more the average amount of lead investments. The top amount of exits for fund were in 2015. The fund is generally included in 13-24 deals every year.